Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
23.88
+1.81 (8.20%)
At close: Mar 9, 2026, 4:00 PM EDT
24.70
+0.82 (3.43%)
After-hours: Mar 9, 2026, 7:37 PM EDT
Syndax Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,106 | 1,826 | 1,128 | 1,833 | 1,733 | 1,184 | |
| Market Cap Growth | 54.31% | 61.82% | -38.43% | 5.75% | 46.42% | 12.95% | |
| Enterprise Value | 2,038 | 1,717 | 723 | 1,461 | 1,384 | 969 | |
| Last Close Price | 23.88 | 21.01 | 13.22 | 21.61 | 25.45 | 21.89 | |
| PE Ratio | - | - | - | - | - | 47.49 | |
| PS Ratio | 12.22 | 10.60 | 47.65 | - | - | 8.47 | |
| PB Ratio | 32.30 | 28.25 | 3.92 | 3.31 | 3.71 | 2.90 | |
| P/TBV Ratio | 32.59 | 28.25 | 3.92 | 3.31 | 3.71 | 2.90 | |
| P/FCF Ratio | - | - | - | - | - | 40.81 | |
| P/OCF Ratio | - | - | - | - | - | 40.63 | |
| EV/Sales Ratio | 11.82 | 9.96 | 30.53 | - | - | 6.94 | |
| EV/EBITDA Ratio | - | - | - | - | - | 36.90 | |
| EV/EBIT Ratio | - | - | - | - | - | 36.96 | |
| EV/FCF Ratio | - | - | - | - | - | 33.42 | |
| Debt / Equity Ratio | 5.35 | 5.35 | 1.20 | 0.00 | 0.00 | 0.05 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 0.79 | |
| Debt / FCF Ratio | - | - | - | - | - | 0.72 | |
| Net Debt / Equity Ratio | -1.06 | -1.06 | -0.82 | -1.04 | -1.03 | -1.04 | |
| Net Debt / EBITDA Ratio | 0.25 | 0.25 | 0.70 | 2.51 | 3.19 | -16.21 | |
| Net Debt / FCF Ratio | 0.21 | 0.21 | 0.86 | 3.59 | 3.62 | -14.68 | |
| Asset Turnover | 0.28 | 0.28 | 0.04 | - | - | 0.37 | |
| Inventory Turnover | 12.84 | 12.84 | - | - | - | - | |
| Quick Ratio | 4.03 | 4.03 | 5.76 | 9.96 | 16.81 | 21.62 | |
| Current Ratio | 4.40 | 4.40 | 5.82 | 10.00 | 16.85 | 21.68 | |
| Return on Equity (ROE) | -161.82% | -161.82% | -75.69% | -40.98% | -34.10% | 7.55% | |
| Return on Assets (ROA) | -27.25% | -27.25% | -31.77% | -25.89% | -20.03% | 4.37% | |
| Return on Capital Employed (ROCE) | -66.80% | -66.80% | -54.70% | -41.40% | -32.40% | 6.10% | |
| Earnings Yield | -13.55% | -15.63% | -28.25% | -11.42% | -8.62% | 2.11% | |
| FCF Yield | -15.34% | -17.70% | -24.36% | -8.76% | -7.71% | 2.45% | |
| Buyback Yield / Dilution | -1.17% | -1.17% | -21.67% | -15.82% | -13.31% | -29.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.